• Successful $609,000 placement, strengthening cash position
• Commencement of seaweed operations in Indonesia, first sales secured
• R&D progress on probiotic beverage and mineral extraction from seaweed

BPH Global Limited (ASX: BP8), a plant-based biotechnology company, released its Appendix 4C and Quarterly Activities Report for the period ended 30 June 2025. During the quarter, the company maintained strong engagement with prospective investors, culminating in a successful $609,000 placement. The company also focused on the development of its seaweed business in Indonesia, including the registration of a wholly-owned subsidiary, the appointment of key personnel, and the acquisition of operational infrastructure. The company transitioned from establishment to early-stage commercial operations, securing its first seaweed sales under formal offtake and sales cooperation agreements. These initial sales validate market demand and establish a commercial foothold in both domestic and international markets. The company also progressed complementary R&D activities, including the development of a probiotic green seaweed water kefir beverage in collaboration with Singapore Polytechnic, and research into the extraction of minerals, nano-minerals, and chemicals from seaweed biomass in partnership with Temasek Polytechnic. While the mineral extraction research has faced some challenges, the company is now exploring biological extraction techniques and negotiating a new six-month R&D program with Temasek Polytechnic.

The company is advancing several operational initiatives aimed at expanding its supply chain capacity, increasing trading volumes, and enhancing infrastructure to support long-term growth. This includes collaborating with farmers and cooperatives to ensure consistent seaweed supply, scaling volumes to meet growing demand, and upgrading its processing facilities in Indonesia.